Profund Advisors LLC lowered its holdings in Balchem Co. (NASDAQ:BCPC – Free Report) by 6.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,891 shares of the basic materials company’s stock after selling 129 shares during the period. Profund Advisors LLC’s holdings in Balchem were worth $239,000 as of its most recent SEC filing.
Several other large investors also recently made changes to their positions in the business. Franklin Resources Inc. increased its position in shares of Balchem by 4.6% in the second quarter. Franklin Resources Inc. now owns 2,125 shares of the basic materials company’s stock worth $276,000 after acquiring an additional 93 shares in the last quarter. Great West Life Assurance Co. Can increased its position in shares of Balchem by 0.5% in the first quarter. Great West Life Assurance Co. Can now owns 28,110 shares of the basic materials company’s stock worth $3,943,000 after acquiring an additional 132 shares in the last quarter. US Bancorp DE grew its holdings in Balchem by 0.9% during the 1st quarter. US Bancorp DE now owns 19,071 shares of the basic materials company’s stock valued at $2,412,000 after purchasing an additional 162 shares in the last quarter. Mercer Global Advisors Inc. ADV grew its holdings in Balchem by 11.3% during the 3rd quarter. Mercer Global Advisors Inc. ADV now owns 1,819 shares of the basic materials company’s stock valued at $221,000 after purchasing an additional 184 shares in the last quarter. Finally, Mackenzie Financial Corp grew its holdings in Balchem by 11.7% during the 1st quarter. Mackenzie Financial Corp now owns 1,850 shares of the basic materials company’s stock valued at $253,000 after purchasing an additional 194 shares in the last quarter. Institutional investors and hedge funds own 87.91% of the company’s stock.
Balchem Trading Down 0.3 %
NASDAQ BCPC opened at $132.23 on Friday. Balchem Co. has a 12 month low of $116.68 and a 12 month high of $143.88. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.94 and a quick ratio of 1.85. The company has a market capitalization of $4.26 billion, a price-to-earnings ratio of 43.07 and a beta of 0.69. The company’s fifty day moving average price is $134.39 and its two-hundred day moving average price is $130.48.
Wall Street Analyst Weigh In
BCPC has been the subject of a number of recent analyst reports. HC Wainwright raised their price target on shares of Balchem from $150.00 to $165.00 and gave the company a “buy” rating in a report on Monday, July 31st. StockNews.com initiated coverage on shares of Balchem in a report on Thursday, August 17th. They set a “hold” rating for the company.
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.
- Five stocks we like better than Balchem
- How and Why to Invest in Oil Stocks
- These 3 Wood Stocks are about to go on Discount
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Same Coin, Different Sides: 2 Observability Stocks Reverse Ways
- Golden Cross Stocks: Pattern, Examples and Charts
- 3 Stocks Awaiting Winter Winds of Opportunity
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.